Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
PUT
Snap
SNAP
$8.48B
| $3.16M | ﹤0.01% |
410,000
-4,305,000
| -91% | -$35.7M |
|
2502
Vital Farms
VITL
$548M
| $3.15M | ﹤0.01% |
76,665
-15,731
| -17% | -$683K |
|
2503
First Bancorp
FBNC
$2.64B
| $3.15M | ﹤0.01% |
59,612
-26,593
| -31% | -$1.36M |
|
2504
Dentsply Sirona
XRAY
$2.83B
| $3.15M | ﹤0.01% |
248,273
+82,864
| +50% | +$1.2M |
|
2505
PUT
Peloton Interactive
PTON
$2.79B
| $3.15M | ﹤0.01% |
350,000
| – | – |
|
2506
Perrigo
PRGO
$1.48B
| $3.15M | ﹤0.01% |
141,398
-224,689
| -61% | -$5.49M |
|
2507
Ingles Markets
IMKTA
$1.74B
| $3.15M | ﹤0.01% |
45,234
-6,860
| -13% | -$457K |
|
2508
Utz Brands
UTZ
$1.25B
| $3.14M | ﹤0.01% |
258,660
+102,576
| +66% | +$1.36M |
|
2509
Diamondrock Hospitality Co
DRH
$2.74B
| $3.14M | ﹤0.01% |
394,327
-43,600
| -10% | -$353K |
|
2510
NetEase
NTES
$84.2B
| $3.14M | ﹤0.01% |
20,644
+943
| +5% | +$130K |
|
2511
CoreCivic
CXW
$3B
| $3.14M | ﹤0.01% |
154,096
-53,402
| -26% | -$1.11M |
|
2512
NBT Bancorp
NBTB
$2.75B
| $3.13M | ﹤0.01% |
74,904
-37,237
| -33% | -$1.6M |
|
2513
QuidelOrtho
QDEL
$1.21B
| $3.12M | ﹤0.01% |
106,078
-230,056
| -68% | -$6.29M |
|
|
GSRT
2514
DELISTED
GSR III Acquisition Corp
GSRT
| $3.11M | ﹤0.01% |
+300,000
| New | +$3.17M |
|
2515
Atour Lifestyle Holdings
ATAT
$4.78B
| $3.11M | ﹤0.01% |
82,619
+47,835
| +138% | +$1.75M |
|
2516
Acushnet Holdings
GOLF
$5.98B
| $3.11M | ﹤0.01% |
39,561
-16,988
| -30% | -$1.32M |
|
2517
CALL
Rocket Lab Corp
RKLB
$44B
| $3.09M | ﹤0.01% |
64,500
| – | – |
|
2518
Vishay Intertechnology
VSH
$5.43B
| $3.08M | ﹤0.01% |
201,472
-28,183
| -12% | -$447K |
|
|
ALEX
2519
DELISTED
Alexander & Baldwin
ALEX
| $3.08M | ﹤0.01% |
169,406
-36,406
| -18% | -$668K |
|
2520
CALL
Boston Scientific
BSX
$72B
| $3.08M | ﹤0.01% |
31,500
| – | – |
|
2521
Harmony Biosciences
HRMY
$2.06B
| $3.07M | ﹤0.01% |
111,514
-15,599
| -12% | -$537K |
|
2522
ePlus
PLUS
$2.45B
| $3.07M | ﹤0.01% |
43,267
-11,157
| -21% | -$787K |
|
2523
Tango Therapeutics
TNGX
$4.43B
| $3.07M | ﹤0.01% |
365,680
+227,030
| +164% | +$1.54M |
|
2524
Quaker Houghton
KWR
$2.89B
| $3.07M | ﹤0.01% |
23,297
-7,104
| -23% | -$934K |
|
2525
HDFC Bank
HDB
$124B
| $3.07M | ﹤0.01% |
89,760
+23,702
| +36% | +$874K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.